Midatech: The Story of a Nanoparticle Start-Up




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Midatech: The Story of a Nanoparticle Start-Up
Released on: July 01, 2007. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this exclusive interview, Fintan Walton talks to Tom Rademacher, President of Midatech, about the formation of the biotech, Professor Rademacher's fifth start-up company.
  • Summary
  • Participants
  • Company
In this exclusive interview, Fintan Walton talks to Tom Rademacher, President of Midatech, about the formation of the biotech, Professor Rademacher's fifth start-up company. Tom discusses Midatech's business model, and why a centralised group company structure with three fully owned subsidiaries suited the development of its technology. He also talks in depth about the science behind the company's nanoparticle technology, as well as its applications in therapeutics, diagnostics and surface coatings.
Tom Rademacher is President of Midatech and Professor of Molecular Medicine at University College London (UCL) Medical School. Professor Rademacher obtained a degree in Medicine in 1976 and a PhD in Biochemistry in 1980, both at the University of Wisconsin-Madison. He was co-founder and Clinical and Research Director of the Glycobiology Institute at the University of Oxford before moving to UCL in 1991. He is the author of over 150 research publications and holds 50 patents.
Midatech